Decutan

Quick links to important sections

Decutan

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Decutan

Property Description
Active ingredient Isotretinoin (13-cis-retinoic acid)
Form Soft gelatine capsule
Pharmacological class Systemic Retinoid
General purpose Addresses foundational causes of severe dermatological conditions
Origin Synthetic derivative of Vitamin A

Decutan: Classification and Active Ingredient

Decutan is a highly potent, prescription-only medicine that belongs to the Systemic Retinoid pharmacological class. Its single active ingredient is Isotretinoin, chemically identified as 13-cis-retinoic acid. This medication is a powerful synthetic compound, closely related to Vitamin A, designated for serious, unresponsive dermatological conditions. The classification as a Systemic Retinoid signifies that the compound is absorbed and exerts a comprehensive influence throughout the body, providing a deep-acting effect distinct from localized surface treatments. As a systemic retinoid, Isotretinoin modifies critical cellular functions related to skin structure.

Pharmaceutical Form and General Purpose

Decutan is formulated for oral administration and is supplied as a soft gelatine capsule. The Isotretinoin is suspended within an oil or lipophilic excipient, which is a necessary pharmaceutical design to ensure the proper absorption of the fat-soluble active compound into the systemic circulation. This formulation is a distinguishing feature, ensuring the drug reaches the systemic circulation effectively. The general therapeutic purpose of Decutan is to address the foundational pathology of severe, persistent skin disorders. This is achieved through its primary mechanism of regulation, which results in a profound reduction in the size and activity of the sebaceous glands and a sustained inhibition of sebum production. This action targets the root issue of extensive, difficult-to-manage skin problems.

Regulatory References

  1. Isotretinoin: MedlinePlus Drug Information
  2. Tretinoin - StatPearls - NCBI Bookshelf - NIH

What side effects are possible with Decutan?

Possible Side Effects and Safety Information

The official safety profile of Decutan (Isotretinoin) is defined by its systemic effects and regulatory constraints, which are formally classified by government health authorities.

Serious Regulatory Safety Constraints

The medication is subject to an absolute contraindication in pregnancy due to the extremely high, documented risk of severe birth defects (teratogenicity). Furthermore, the label requires avoiding concomitant use with tetracycline antibiotics due to an increased risk of a serious neurological condition known as benign intracranial hypertension (pseudotumor cerebri). Patients are also restricted from donating blood during treatment and for a specified time afterward due to the teratogenic risk.

Frequency-Classified Adverse Reactions

The majority of documented adverse events fall into the Very Common frequency class (geq1/10). These include expected mucocutaneous effects such as dry lips (cheilitis), dry skin, dry eyes, and conjunctivitis. Other very common effects involve the musculoskeletal system (e.g., arthralgia, back pain) and metabolism (e.g., elevated triglycerides and liver transaminases).

Reactions categorized as Rare to Very Rare include serious systemic events. Psychiatric disorders, specifically depression and officially documented instances of suicidal ideation and suicide attempts, are listed as rare. Very rare adverse reactions include acute pancreatitis, inflammatory bowel disease (Crohn's, ulcerative colitis), and severe blistering skin reactions like Stevens-Johnson syndrome.

Population and Time-Related Notes

Specific safety considerations exist for adolescents, including documented risks concerning premature epiphyseal closure and changes in bone mineral density. In terms of exposure, the label notes that a temporary worsening of acne may occur at the start of treatment, and certain visual effects, such as decreased night vision, may potentially persist after therapy has ceased.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Decutan (Isotretinoin) overdose is strictly based on the recognized toxicity associated with excessive intake of Vitamin A derivatives, clinically known as hypervitaminosis A. Documented acute clinical manifestations found in prescribing information include transient headache which may be severe, along with vomiting, facial flushing, and ataxia (loss of physical coordination).

The regulatory documentation identifies the potential for serious, life-threatening outcomes affecting the central nervous system and the liver. These risks include the development of Benign Intracranial Hypertension (Pseudotumor Cerebri) and significant hepatic impairment.

Due to these severe possibilities, regulatory authorities mandate that any suspected overexposure requires the patient to seek immediate medical attention. Contact emergency services immediately if severe or neurological symptoms, such as a persistent headache, are observed. The official labeling states that no specific antidote is known for Isotretinoin toxicity; consequently, management must be restricted to symptomatic and supportive treatment. Additionally, official documents note that overexposure in women of childbearing potential carries a uniquely severe teratogenic risk, which is a primary concern in the overdose scenario.

Therapeutic Uses of Decutan

What Decutan Treats: Main Uses and Benefits

Decutan (Isotretinoin) is a medication considered relevant in contexts where additional symptomatic support is needed. It is often used in situations involving recurrent or episodic manifestations that are difficult to manage. Its use includes forms of acne that are resistant to adequate courses of standard treatments.

Management of Severe Symptoms and Scarring Risk

The medication is commonly used to help with managing severe acne vulgaris, including aggressive forms such as nodular and cystic acne. It is applied in conditions characterized by periods of heightened symptoms and is relevant in clinical settings that involve acute or unstable symptom patterns. The use of Decutan is associated with addressing symptom clusters that may become intense or disruptive, particularly the painful, deep-seated inflammatory symptoms and the associated widespread congestion.

By addressing the symptoms related to inflammatory or irritative states, the therapy may assist with easing the impact of symptoms that can lead to permanent scarring and potential disfigurement. This provides symptomatic relief that helps patients cope more steadily and supports general well-being.


Quick Fact: Relief for Deep Inflammatory Lesions Decutan is generally used in clinical scenarios where the patient experiences symptoms related to inflammatory or irritative states and where symptoms that interfere with daily functioning include painful, deep-seated lesions.


Eligibility and Restrictions for Use

Decutan (Isotretinoin) is a highly restricted, prescription-only medicine with strict population eligibility rules established by government health authorities. It is reserved for adults and adolescents 12 years of age and older who have severe nodular acne that is unresponsive to conventional systemic therapy.


Absolute Contraindications

The medicine is absolutely contraindicated and must not be used by the following populations:

  • Pregnant women and women who are breastfeeding.
  • Females of childbearing potential who are non-compliant with the mandatory Pregnancy Prevention Programme (PPP) or REMS.
  • Patients with pre-existing Hypervitaminosis A.
  • Patients with significantly impaired hepatic function (liver disease).
  • Patients with severely elevated blood lipid levels (severe hyperlipidaemia).
  • Patients receiving concomitant tetracycline antibiotics.
  • Patients with documented hypersensitivity to isotretinoin or any retinoid excipients, including peanut or soy (if present in the capsule formulation).

Conditional Use and Age Limitations

Use is not recommended for children under 12 years of age. Use in older adults (over 65 years) is not established due to insufficient data. Patients with a history of depression or psychosis, or those with diabetes mellitus, require special caution, as documented in regulatory warnings.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Decutan (Isotretinoin) has documented interaction patterns that impose specific constraints on co-administration with other medicines and products. The regulatory profile explicitly classifies certain combinations as strictly prohibited. Co-administration with Tetracycline antibiotics (e.g., Minocycline, Doxycycline) is contraindicated due to an officially documented, additive risk of Intracranial Hypertension (Pseudotumor Cerebri). Similarly, the use of Vitamin A or Vitamin A supplements is prohibited due to the risk of additive toxic effects leading to hypervitaminosis A.


Regarding Exposure and Effectiveness Alteration, the drug must be administered with a high-fat meal to ensure proper systemic exposure. The use of Progestin-Only Oral Contraceptives is not considered a suitable contraceptive method because their effectiveness may be officially documented as decreased. This necessitates the use of two alternative forms of effective contraception for one month before, during, and one month after therapy.


Pharmacodynamic interactions include those with medicines that reinforce specific risks. Co-administration with Systemic Corticosteroids or Phenytoin is cautioned against, as these combinations are associated with an officially described additive risk of bone loss. Caution is also advised regarding the consumption of alcohol, which can increase the risk of elevated serum triglycerides and liver-related effects. Finally, certain dermatological procedures like waxing and dermabrasion must be avoided during treatment and for a period afterward due to the increased risk of scarring.

Mechanism of Action

How Decutan Works

Decutan's mechanism is a systemic, receptor-mediated process that alters the physiology of the skin's secretory unit.


Nuclear Receptor Modulation and Sebocyte Apoptosis

The drug’s active compound acts as an agonist on specific Retinoic Acid Receptors (RARs) inside the cell nucleus, which begins the molecular cascade. This binding activates a transcriptional control program that ultimately triggers the selective programmed cell death (apoptosis) of sebocytes. This cascade results in the atrophy (shrinkage) of the sebaceous glands, leading to inhibition of sebum production (sebaceous suppression).


Follicular Keratinocyte Modulation

The retinoid mechanism also modulates the differentiation and proliferation of keratinocytes lining the hair follicle. This action modulates the abnormal cell turnover known as follicular hyperkeratinization, reducing the accumulation of dead cells within the follicle. This combined action provides a broad modulation of the physiological processes within the sebaceous unit.

Dosage and Administration Information

How Decutan Is Used: Administration Guidelines

Decutan (Isotretinoin) is administered orally and involves specific protocols regarding dosage calculation, frequency, and conditions of intake.

Dosing and Administration Protocol

The standard approach to using this medicine is defined by a weight-based regimen and a time-limited course.

Category Standard Instruction
Route of Administration Oral route using soft gelatine capsules.
Dosing Schedule The typical initial and maintenance dose is 0.5 to 1 mg/kg per day. Dosing may be increased to a maximum of 2 mg/kg per day for very severe or resistant disease.
Frequency The total daily dose is generally taken in two divided doses.
Timing with Meals Capsules are taken with food, preferably a meal containing fat, to ensure optimal absorption.
Course Duration A single course typically lasts for 15 to 20 weeks, aiming for a cumulative dose of 120–150 mg/kg.

Procedural and Population-Specific Conditions

The administration method involves swallowing capsules whole with liquid; they are not to be chewed or crushed.

  • Retreatment Interval: If a second course is required, a minimum of two months elapses without treatment before initiating retreatment.
  • Renal Impairment: For cases involving severe kidney problems, treatment often begins with a lower starting dose, such as 10 mg per day, which can then be gradually adjusted.
  • Missed Doses: If a dose is missed, the standard procedure is to skip the missed dose and return to the regular schedule, avoiding a double dose.

Recent Clinical Evidence

Research evidence / Overview of studies for Decutan

Severe Acne (Nodular, Conglobate, or Acne at Risk of Permanent Scarring)

The active ingredient in Decutan, isotretinoin, has been the subject of research exploring its role in managing severe forms of acne that have not responded to standard treatments like systemic antibiotics and topical therapies. The evidence mostly comes from a long history of clinical practice, case series, and retrospective studies (looking back at patient records), although some controlled clinical trials have also been conducted.

  • What was studied: Researchers primarily looked at how isotretinoin affects the number of inflammatory and non-inflammatory acne lesions (like nodules, cysts, and blackheads) and how often acne returns after treatment is finished.
  • What was found: Research so far indicates that studies evaluating isotretinoin reported a noticeable and often sustained reduction in the severity of acne. Studies suggest that a large percentage of people who completed a course of treatment reported clearance or substantial changes in their acne. Some studies suggest that the total amount of medication taken over the course of treatment (the "cumulative dose") was associated with a lower risk of acne returning.
  • What remains uncertain: There is variability in the reported rates of acne returning after treatment, ranging widely across different studies. Potential reasons for this difference explored in research include how "relapse" is defined, the specific patient groups studied, and variations in the treatment duration or dose used.

Other Skin Conditions

Beyond its main use for severe acne, research has explored the use of isotretinoin for certain other skin issues. These studies are often smaller or focus on specific patient groups, and the evidence is more limited than for severe acne.


Special Populations (Adolescents)

Because acne is very common in teenagers, a significant portion of the research has included this age group. The findings in adolescents were similar to those in adults, with studies reporting positive changes in acne severity. However, some evidence suggests an association between younger age and a potentially higher rate of acne returning compared to older individuals. It remains unclear whether the best treatment strategy for adolescents should be different from that used for adults to address the potential for acne returning.

Key Studies & References

  1. Isotretinoin therapy and the incidence of acne relapse: a nested case-control study (Predictors of Relapse in Large Cohort)
  2. Outcomes and Adverse Effects of Isotretinoin in Acne Treatment: A Systematic Review (General Efficacy and Adverse Effects)

Frequently Asked Questions (FAQ)

Common questions about Decutan (FAQ)


Q: Is Decutan the same kind of medicine as other common acne treatments?

A: Decutan is a type of medicine known as a systemic retinoid, which is related to Vitamin A. According to official documents, it works throughout the body by targeting receptors inside cells to suppress the sebaceous (oil) glands and alter the skin's growth processes. This mechanism establishes a key difference between Decutan and standard topical or antibiotic treatments.


Q: Is Decutan considered a 'cure' for acne?

A: Studies and official information on Decutan do not describe the outcome as a 'cure.' Instead, research indicates that the medicine provides a noticeable and often sustained reduction in the severity of acne. The long-term outcome is often discussed in terms of the rate of acne returning, or 'relapse,' which can vary among patients.


Q: Can Decutan be used by children or adolescents under the age of 18?

A: Official product information states that Decutan is indicated for non-pregnant patients who are 12 years of age and older. Like all patients, adolescents must meet specific criteria for severe acne that has not responded to other treatments before the medicine is prescribed.


Q: Are there any long-term effects of taking Decutan that users should be aware of?

A: Official safety information notes that certain effects, such as decreased night vision, have the potential to persist even after treatment has finished. For adolescents, a documented risk concerns premature epiphyseal closure, which is the premature stopping of long bone growth.


Q: Can Decutan cause severe dryness of the lips and skin, and is there a way to manage this?

A: Yes, the medicine is documented to cause very common effects on the skin and mucous membranes, specifically severe dryness of the lips (cheilitis) and skin. Regulatory-aligned patient guidance suggests the use of rich, non-comedogenic moisturizers and lip balms to help manage these documented effects.


Q: Can Decutan be taken at the same time as certain antibiotics?

A: Official regulatory documents specify that co-administration with Tetracycline antibiotics (such as minocycline or doxycycline) is contraindicated, meaning it must be avoided. This is due to a specific risk of increased pressure around the brain. Whether other types of antibiotics can be used requires careful review of the official prescribing information.


Q: Are there any herbal or dietary supplements that are known to interact with Decutan?

A: The use of Vitamin A or Vitamin A supplements is officially prohibited due to the risk of additive toxic effects on the body. Furthermore, specific patient safety information may advise against the use of certain herbal supplements, such as St. John’s wort, because it can potentially interfere with the effectiveness of required birth control methods.


Q: How does Decutan affect the liver, and why are blood tests needed during treatment?

A: The drug is associated with changes to the liver and metabolism, including elevated liver enzymes and changes in blood fat levels. Regulatory guidelines mandate baseline and regular blood tests to monitor liver function and lipid (fat) levels. Monitoring is performed regularly during treatment to help manage potential adverse effects on the liver and blood fat levels.


Q: Does Decutan cause skin to become thinner or more fragile?

A: Official documents state that certain cosmetic procedures, such as waxing and dermabrasion, must be avoided during treatment and for a period afterward. This requirement is in place due to an officially described increased risk of scarring, which is indicative of altered skin healing.


Q: How does Decutan differ from topical retinoids like tretinoin or adapalene?

A: Decutan is a systemic retinoid, meaning it works internally throughout the body to treat acne. Its mechanism involves causing the programmed death (apoptosis) of the sebaceous (oil) glands, leading to significant oil suppression. Topical retinoids work on the skin's surface but do not cause this systemic gland atrophy.


Q: How does Decutan affect inflammatory conditions other than acne?

A: Beyond its primary use for severe acne, official research has explored the drug's use for 'certain other skin issues.' However, regulatory documents state that these studies are generally smaller and the evidence for these other uses is more limited compared to its established role in severe acne.


Q: Can Decutan be used by individuals who have certain pre-existing health conditions, like diabetes or high blood pressure?

A: Official product information notes that patients with severe kidney problems often require a lower starting dose. Caution is generally advised and closer monitoring may be required for individuals with significant pre-existing conditions, such as diabetes, due to potential effects on metabolism and blood fat levels.


Q: Does Decutan have the potential to interact with certain seizure medications?

A: Official documents advise caution regarding co-administration with the seizure medication Phenytoin (an anticonvulsant). This caution is due to an officially described additive risk of bone loss when the two medicines are taken together.


Q: Are there any reported long-term effects on the bones or joints?

A: The drug is associated with very common joint aches (arthralgia) and back pain during treatment. The risk of bone loss is specifically mentioned when the medicine is taken alongside other drugs like systemic corticosteroids or Phenytoin. For adolescents, official information also notes a risk of premature bone growth closure.


Q: Do studies suggest that the improvement from Decutan is permanent for most people?

A: Official research focuses on achieving a noticeable and often sustained reduction in acne severity, rather than promising permanence. The rate at which acne returns, or 'relapse,' is variable among patients. Some studies suggest that achieving a total amount of medication over the treatment period (the cumulative dose) is associated with a lower risk of relapse.


Q: Can Decutan affect a person's ability to drive safely due to vision or drowsiness issues?

A: Official safety information lists side effects such as decreased night vision and drowsiness or tiredness. Patients who experience these effects should be aware that their ability to drive or operate heavy machinery may be affected.


Q: What is the difference between Decutan and oral antibiotics for acne?

A: Decutan is a retinoid that acts systemically to suppress the sebaceous glands and reduce oil production through a mechanism known as programmed cell death (apoptosis). This is fundamentally different from oral antibiotics, which target bacteria and inflammation. The medicine is indicated for severe acne that has not responded to treatment with systemic antibiotics.


Q: How to Store and Dispose of Decutan?

A: Decutan must be stored at a controlled room temperature (20 C to 25 C). For disposal, official governmental guidance (if a drug take-back program is unavailable) typically describes mixing the medicine with an undesirable substance, such as coffee grounds, and placing it in a sealed container for household trash.


Q: How quickly does Decutan typically start to work?

A: Official documents note that some patients may experience a temporary worsening of acne at the start of treatment. The full benefits of the medication are typically observed gradually over the complete course of treatment, which is usually defined as 15 to 20 weeks.


Q: Does Decutan interact with commonly used over-the-counter pain relievers?

A: Regulatory-aligned patient information often advises that common pain relievers like paracetamol (acetaminophen) can be used for mild aches. However, caution is generally advised with any medicine that puts additional stress on the liver, as Decutan can also affect liver enzyme levels.


Q: What kind of sun protection measures are necessary while taking Decutan?

A: Official guidance recommends patients seek shade, wear sun-protective clothing, and apply a broad-spectrum sunscreen with an SPF of 30 or higher to all exposed skin areas, as the medicine causes increased sun sensitivity.


Q: Can a patient stop taking Decutan before the recommended course is finished?

A: The medicine is prescribed for a specific time-limited course aimed at achieving a necessary total (cumulative) dose. Official instructions emphasize the importance of adhering to the scheduled regimen and do not support unauthorized early discontinuation.


Q: Can men who take Decutan still father children safely?

A: Official warnings and restrictions focus exclusively on the high risk of severe birth defects if the patient who can become pregnant takes the drug. Regulatory documents do not contain official warnings or restrictions regarding the drug's effect on sperm or the safety of the male patient's ability to father children.


Q: Does Decutan interact with St. John's wort?

A: Official patient safety materials may warn against taking St. John’s wort while on the medicine. This is because St. John's wort has the potential to reduce the effectiveness of hormonal contraceptives, which are a required component of the official pregnancy prevention program.


Q: Is there a link between Decutan and hair loss?

A: Regulatory-aligned patient information lists temporary hair loss or thinning hair as a possible side effect. This is one of the many adverse reactions that may be documented in official product information.


Q: What happens if a patient gets pregnant during the one-month waiting period before starting Decutan?

A: The official pregnancy prevention program requires women who can become pregnant to have two negative pregnancy tests before the first prescription. If a patient tests positive for pregnancy at any time, including the one-month waiting period, the drug is contraindicated and cannot be initiated.


Q: Is it necessary to use a special lip balm or moisturizer while undergoing Decutan treatment?

A: Because the medicine is associated with very common severe dryness of the skin and lips, patient guidance frequently highlights the importance of using rich, creamy moisturizers and lip balms. While not a requirement for the drug to work, using these products is necessary to help manage the documented side effects.


Q: Can the drug cause a reaction that makes it difficult to swallow or causes throat pain?

A: Regulatory summaries list a dry throat as a potential side effect. Furthermore, documented case reports describe instances of pill esophagitis, a reaction associated with swallowing the capsule, which can lead to discomfort or difficulty swallowing.


Q: Is there a difference in how generic and branded versions of the drug work?

A: According to official regulatory standards for bioequivalence, generic versions of the medicine are considered therapeutically equivalent to the branded version. This means that the generic formulation contains the same active ingredient and is absorbed by the body in a way that provides the same clinical effect.


Q: What should be done if a patient suspects they are having a rare or serious side effect?

A: Official documents list various rare to very rare serious adverse events. Standard protocol typically suggests immediate discontinuation of the medication and prompt medical evaluation if a patient suspects they are experiencing a rare or serious side effect.


Q: Why is Decutan only available through a restricted or special distribution program in some countries?

A: The medicine is subject to a Risk Evaluation and Mitigation Strategy (REMS), such as the iPLEDGE program in the United States. These programs are mandated by regulatory authorities to manage and minimize the extremely high, documented risk of severe birth defects (teratogenicity) associated with the medicine.


Q: Are there certain foods or drinks, besides alcohol, that should be limited while on Decutan?

A: Official guidance requires that the medicine be taken with food, preferably a fatty meal, to ensure optimal absorption. Outside of prohibiting Vitamin A supplements, general food limitations are typically not required. However, patients with elevated blood fat levels (triglycerides) may be advised to modify their dietary fat intake.


Q: Can Decutan affect athletic performance or cause exercise intolerance?

A: The drug is associated with the very common side effects of muscle aches (myalgia) and joint aches (arthralgia). Caution is officially advised regarding strenuous physical exercise because of a rare, dose-related risk of severe muscle injury (rhabdomyolysis).


Q: Is it common to have an increase in nosebleeds while taking Decutan?

A: Official patient safety information and regulatory summaries list epistaxis, or nosebleeds, as a common mucocutaneous side effect of the medicine. This is one of the many effects associated with the drug's action on the skin and mucous membranes.

How should Decutan be stored and disposed of?

How to Store and Dispose of Decutan?

Decutan (isotretinoin) must be stored according to specific regulatory requirements to maintain its stability and effectiveness.

Storage Requirements

  • Temperature: Store at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). Do not freeze.
  • Protection: Keep the capsules in the original container and ensure the cap is tightly closed. The medication must be protected from excessive moisture, light, and heat.
  • Child Safety: It is mandatory to store the medicine in a secure place, out of the sight and reach of children and pets, due to its potent nature.

Disposal Instructions

To dispose of Decutan safely, drug take-back programs are the preferred option. If a program is unavailable, official guidelines recommend mixing the capsules (without opening them) with an unappealing substance, such as coffee grounds or kitty litter. This mixture should then be placed into a sealed bag or container and discarded with the household trash. Do not flush Decutan down a toilet or pour it down a drain unless specifically instructed by local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Decutan found in:

A-Z Index: